Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies.
暂无分享,去创建一个
M. Brandeau | K. McDonald | D. Owens | D. Bravata | G. Zaric | J. Holty | E. R. Wilhelm
[1] S. Lemeshow,et al. Length of Stay Data as a Guide to Hospital Economic Performance for ICU Patients , 2003, Medical care.
[2] Simon Liu,et al. System Performance Modeling in C4ISR/Weapon System Design and Development , 2001 .
[3] David M. Bell,et al. Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of Anthrax , 2002, Emerging infectious diseases.
[4] C. Terriff,et al. Citywide pharmaceutical preparation for bioterrorism. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[5] D K Owens,et al. Regionalization of bioterrorism preparedness and response. , 2004, Evidence report/technology assessment.
[6] Robert J Weber,et al. Impact of intensive care unit (ICU) drug use on hospital costs: A descriptive analysis, with recommendations for optimizing ICU pharmacotherapy , 2003, Critical care medicine.
[7] Marc Mangel,et al. Weapon acquisition with target uncertainty , 1985 .
[8] J. Koplan. CDC's Strategic Plan for Bioterrorism Preparedness and Response , 2001, Public health reports.
[9] G. Case,et al. Hospital preparedness for biological and chemical terrorism in central New Jersey. , 2001, New Jersey medicine : the journal of the Medical Society of New Jersey.
[10] N. Crepaz,et al. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States , 2011, Cancer Causes & Control.
[11] Douglas K Owens,et al. Systematic Review: A Century of Inhalational Anthrax Cases from 1900 to 2005 , 2006, Annals of Internal Medicine.
[12] Case Gg,et al. Hospital preparedness for biological and chemical terrorism in central New Jersey. , 2001 .
[13] K. Pletcher. PREVENTIVE THERAPY. , 1964, Military medicine.
[14] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[15] D. Buckeridge,et al. Systematic Review: Surveillance Systems for Early Detection of Bioterrorism-Related Diseases , 2004, Annals of Internal Medicine.
[16] D K Owens,et al. Interpretation of cost-effectiveness analyses , 1998, Journal of general internal medicine.
[17] C. P. Quinn,et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. , 2001, Emerging infectious diseases.
[18] D. Commerce. Statistical abstract of the United States , 1978 .
[19] Douglas Owens,et al. Cost-Effectiveness of Defending against Bioterrorism: A Comparison of Vaccination and Antibiotic Prophylaxis against Anthrax , 2005, Annals of Internal Medicine.
[20] Ben L. Erdreich,et al. Civil Service Evaluation. The Evolving Role of the U.S. Office of Personnel Management. A Report concerning Significant Actions of the U.S. Office of Personnel Management. , 1998 .
[21] T. O'Toole,et al. A plague on your city: observations from TOPOFF. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] I. Brook. The prophylaxis and treatment of anthrax. , 2002, International journal of antimicrobial agents.
[23] L. Grummer-Strawn,et al. Adherence to Antimicrobial Inhalational Anthrax Prophylaxis among Postal Workers, Washington, D.C., 2001 , 2002, Emerging infectious diseases.
[24] A. Mushlin,et al. Modeling the Public Health Response to Bioterrorism: Using Discrete Event Simulation to Design Antibiotic Distribution Centers , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.
[25] S. Wiersma,et al. Mass vaccination campaign following community outbreak of meningococcal disease. , 2002, Emerging infectious diseases.
[26] R. Brookmeyer,et al. The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak. , 2001, Biostatistics.
[27] J. P. Zimmerman. Personnel Management , 1951, Nature.
[28] R. Brookmeyer,et al. Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Osterholm. How to vaccinate 30,000 people in three days: realities of outbreak management. , 2001, Public health reports.
[30] David L. Craft,et al. Emergency response to an anthrax attack , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Brandeau,et al. Modeling the Logistics of Response to Anthrax Bioterrorism , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.
[32] C D Treser,et al. Hospital preparedness for victims of chemical or biological terrorism. , 2001, American journal of public health.
[33] Elizabeth R. Zell,et al. Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence , 2002, Emerging infectious diseases.
[34] Gerald G. Brown,et al. An Optimization Model for Modernizing the Army's Helicopter Fleet , 1991 .